Answers are grounded in this paper and cite their sources.
Patients with nodal/paranodal antibodies represent a specific subgroup of inflammatory peripheral neuropathies, whose clinical presentation with a prolonged subacute phase, additional symptoms such as ataxia and tremor, and poor treatment response to IV immunoglobulin (IVIG) often differs from classic Guillain-Barré syndrome (GBS) or chronic inflammatory demyelinating polyneuropathy (CIDP).1 The authors thank Valerie Pichler and Sopie Dürauer for technical assistance and Andreas Spittler from the Flow Cytometry Core facility of the MUV for technical support.
No takes yet. Share an insight, caveat, or question.
Simoni et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: